Last reviewed · How we verify
NCT02905929
Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease
NA trial testing ActivPAL inclinometer in Sedentary Lifestyle in 254 participants. Completed in 30 March 2022.
15 April 2020
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 254 |
| Start date | 1 April 2017 |
| Primary completion | 15 April 2020 |
| Estimated completion | 30 March 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- ActivPAL inclinometer
- Phone counseling call: Breaking up sitting time
- In-person counseling: Breaking up sitting time
- Phone counseling call: Healthy living
- Tools to prompt standing
- In-person counseling: Healthy living
Conditions studied
- Sedentary Lifestyle — all drugs for Sedentary Lifestyle →
Sponsor
University of California, San Diego
Who can join
55 and older, female only, with Sedentary Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Project 2 of the University of California, San Diego (UCSD) American Heart Association (AHA) Women's Health Program will assess 3-month changes in sitting time, standing time, physical activity and blood pressure in a randomized control trial (RCT). This 2-arm RCT will occur in the community with post menopausal Latina women (N=250) who spend at least 8 hrs/day sitting and have increased risk for cardiovascular disease through high BMI and other cardiometabolic risk factors. Women will be identified through the San Ysidro Health Center and assessed at the South Bay Latino Research Center.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Arriba por la Vida Estudio (AVE): Study protocol for a standing intervention targeting postmenopausal Latinas.
Takemoto M, Schechtman M, Villa N, Talavera G, et al · · 2019 · cited 3× · PMID 30771560 · DOI 10.1016/j.cct.2019.02.004
Verify or expand the search:
- PubMed search for NCT02905929
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sedentary Lifestyle
Currently open trials in the same condition.
- NCT03511352 — Sedentary Behavior Interrupted: A Trial of Acute Effects on Biomarkers of Healthy Aging · NA · active not recruiting
- NCT03356262 — The QUebec Adipose and Lifestyle InvesTigation in Youth (QUALITY) Cohort · active not recruiting
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02905929 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 4 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02905929.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing